Drug Guidance for Subsidy 18/01/2021 Tenofovir alafenamide for treating chronic hepatitis B infection NRThe Ministry of Health’s Drug Advisory Committee has not recommended listing tenofovir alafe... See all × 18/01/2021 Tenofovir alafenamide for treating chronic hepatitis B infection NRThe Ministry of Health’s Drug Advisory Committee has not recommended listing tenofovir alafenamide (TAF) on the Medication Assistance Fund (MAF) for treating chronic hepatitis B infection, due to unfavourable cost-effectiveness compared with tenofovir disoproxil fumarate (TDF) at the price proposed by the manufacturer.
General Availability in Public Healthcare Institution Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration Tablet, Film Coated 25 mg Alexandra Hospital Changi General Hospital National University Hospital Sengkang General Hospital Singapore General Hospital Tan Tock Seng Hospital